Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Subcortical band heterotopia (SBH), or “double cortex” syndrome, is an X-linked neuronal migration disorder characterized by bilateral bands of heterotopic gray matter within the cerebral white matter. The DCX gene (HGNC:2714) encodes doublecortin, a microtubule-associated protein essential for proper cortical lamination. Heterozygous DCX mutations in females typically cause SBH, while hemizygous or mosaic mutations in males lead to lissencephaly or SBH, respectively. The association was first demonstrated in a systematic study of 11 unrelated females with SBH in whom 10 distinct DCX loss-of-function variants were identified, including nonsense, splice-site, and missense mutations distributed across the gene (PMID:9618162).
Genetic evidence includes familial and sporadic cases, de novo occurrences, and mosaicism. Segregation in a family with two affected sisters and their mildly affected mother confirmed X-linked inheritance (PMID:10480213). De novo missense and truncating variants have been reported in >150 individuals, comprising ~64% missense, 20% nonsense/frameshift, 10% splice, and 6% large deletions detected by MLPA (PMID:17283321; PMID:23365099). A representative pathogenic variant is c.665C>T (p.Thr222Ile) identified by whole-exome sequencing in a child with SBH and confirmed de novo status (PMID:23583063).
Clinically, SBH presents with early-onset epilepsy—often intractable—and global developmental delay. Female heterozygotes exhibit variable band thickness correlating with severity: thick bands in sporadic cases versus thinner, familial bands in milder forms. Male mosaics may display partial SBH or pachygyria‐SBH overlap. Asymptomatic carrier females with normal MRI have been documented, implicating X-inactivation and mosaicism in phenotypic variability (PMID:10915612).
Functional studies elucidate a haploinsufficiency mechanism. Doublecortin contains tandem DC domains that bind tubulin and promote microtubule polymerization. Patient missense mutations cluster within these domains and impair microtubule co-assembly and stability in vitro and in cultured cells (PMID:10946000; PMID:10749977).
In vivo, Dcx-deficient mice display cortical layering defects and impaired neuronal migration, which can be partially rescued by Lis1 overexpression, highlighting interaction with dynein complexes (PMID:15173193). Loss of DCX also perturbs neuromuscular junction formation, revealing roles beyond cortical development (PMID:25817838).
Integration of genetic and experimental data confirms a Definitive DCX–SBH association. X-linked DCX variants disrupt microtubule dynamics, leading to neuronal migration failure and SBH. Comprehensive mutation analysis, including sequencing and dosage assays, is recommended for diagnosis, genetic counseling, and prenatal detection. Key take-home: DCX testing is clinically actionable in females with SBH and in males with unexplained SBH or lissencephaly spectrum disorders.
Gene–Disease AssociationDefinitiveMutations reported in >150 individuals across ~180 unrelated families, consistent X-linked inheritance, segregation in familial cases, de novo occurrences, and functional studies confirming loss-of-function ([PMID:9618162]; [PMID:10946000]) Genetic EvidenceStrong136 individuals with DCX mutations in SBH including missense, nonsense, frameshift, splice, and mosaic variants; recurrence and de novo in probands reached genetic evidence cap ([PMID:17283321]; [PMID:23365099]) Functional EvidenceStrongMultiple independent functional assays demonstrating DCX’s microtubule-binding, polymerization roles, neuronal migration defects in Dcx-deficient mice, and rescue by Lis1 overexpression ([PMID:10946000]; [PMID:15173193]) |